MARCELLA NOLE: Open Payments
NPI 1659335735 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,961 in 101 payments from 12 companies in 2025. Trend: 2023 $1,966 · 2024 $1,516 · 2025 $1,961
Food & beverage: $1,961
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $722 |
| Janssen Biotech, Inc. | 19 | $414 |
| Madrigal Pharmaceuticals | 8 | $257 |
| Ardelyx, Inc. | 12 | $172 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $73 |
| Ipsen Biopharmaceuticals, Inc | 3 | $72 |
| Phathom Pharmaceuticals, Inc. | 4 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| Celltrion USA Inc. | 2 | $38 |
| GENZYME CORPORATION | 2 | $38 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, IBSRELA, LINZESS, CREON, SKYRIZI, XIFAXAN.
Industry payments across CA — which companies pay providers there.
